Hashimoto's thyroiditis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:
In European countries an atrophic form of [[autoimmune]] thyroiditis ([[Ord's thyroiditis]]) is more common than Hashimoto's thyroiditis.
In European countries an atrophic form of [[autoimmune]] thyroiditis ([[Ord's thyroiditis]]) is more common than Hashimoto's thyroiditis.


The disease begins slowly. It may take months or even years for the condition to be detected. Chronic thyroiditis is most common in women and people with a family history of thyroid disease. It affects between 0.1% and 5% of all adults in Western countries.
It affects between 0.1% and 5% of all adults in Western countries.
   
   
Various autoantibodies may be present against thyroid peroxidase, thyroglobulin and TSH receptors, although a small percentage of patients may have none of these antibodies present.<!-- This is from eMedicine article, see infobox --> A percentage of the population may also have these antibodies without developing Hashimoto's thyroiditis.
Various autoantibodies may be present against thyroid peroxidase, thyroglobulin and TSH receptors, although a small percentage of patients may have none of these antibodies present.  A percentage of the population may also have these antibodies without developing Hashimoto's thyroiditis.
 
==References==
==References==



Revision as of 04:11, 20 September 2012

Hashimoto's thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hashimoto's Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hashimoto's thyroiditis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hashimoto's thyroiditis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hashimoto's thyroiditis epidemiology and demographics

CDC on Hashimoto's thyroiditis epidemiology and demographics

Hashimoto's thyroiditis epidemiology and demographics in the news

Blogs on Hashimoto's thyroiditis epidemiology and demographics

Directions to Hospitals Treating Hashimoto's thyroiditis

Risk calculators and risk factors for Hashimoto's thyroiditis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

This disorder is believed to be the most common cause of primary hypothyroidism in North America. It occurs far more often in women than in men (10:1 to 20:1), and is most prevalent between 45 and 65 years of age.

In European countries an atrophic form of autoimmune thyroiditis (Ord's thyroiditis) is more common than Hashimoto's thyroiditis.

It affects between 0.1% and 5% of all adults in Western countries.

Various autoantibodies may be present against thyroid peroxidase, thyroglobulin and TSH receptors, although a small percentage of patients may have none of these antibodies present. A percentage of the population may also have these antibodies without developing Hashimoto's thyroiditis.

References

Template:WH Template:WS